Edward Fiorentino Net Worth

The estimated Net Worth of Edward Fiorentino is at least $560 millier dollars as of 11 March 2022. Mr. Fiorentino owns over 83,900 units of Senseonics Inc stock worth over $193,520 and over the last 8 years he sold SENS stock worth over $208,631. In addition, he makes $157,500 as Independent Director at Senseonics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Fiorentino SENS stock SEC Form 4 insiders trading

Edward has made over 2 trades of the Senseonics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 83,900 units of SENS stock worth $45,306 on 11 March 2022.

The largest trade he's ever made was selling 109,231 units of Senseonics Inc stock on 25 May 2021 worth over $208,631. On average, Edward trades about 5,082 units every 8 days since 2016. As of 11 March 2022 he still owns at least 491,292 units of Senseonics Inc stock.

You can see the complete history of Mr. Fiorentino stock trades at the bottom of the page.

Edward Fiorentino biography

Edward J. Fiorentino is Independent Director of the Company, since December 2015. Mr. Fiorentino served on the Senseonics, Incorporated Board of Directors from March 2012 to December 2015. Since March 2016, Mr. Fiorentino has served as Chairman and Chief Executive Officer of TerSera Therapeutics, a specialty pharmaceutical company. From August 2013 to January 2016, Mr. Fiorentino has served as Chairman and Chief Executive Officer of Crealta Pharmaceuticals, a specialty pharmaceutical company. From March 2009 to June 2013, he was the Chief Executive Officer of Actient Pharmaceuticals. Prior to Actient, Mr. Fiorentino served in various positions at Abbott Laboratories, including Corporate Vice President of Pharmaceutical Commercial Operations, for more than 20 years. He also previously served as Senior Vice President and President of Abbott Diabetes Care and was Executive Vice President of TAP Pharmaceuticals. Mr. Fiorentino began his career with Bristol-Myers. Mr. Fiorentino received his B.S. in Business Administration from the State University of New York and his M.B.A. from Syracuse University. Our Board of Directors believes that Mr. Fiorentino's substantial healthcare and pharmaceutical experience qualifies him to serve as a director of our Company.

What is the salary of Edward Fiorentino?

As the Independent Director of Senseonics Inc, the total compensation of Edward Fiorentino at Senseonics Inc is $157,500. There are 10 executives at Senseonics Inc getting paid more, with Timothy Goodnow having the highest compensation of $2,211,200.

What's Edward Fiorentino's mailing address?

Edward's mailing address filed with the SEC is 20451 SENECA MEADOWS PARKWAY, , GERMANTOWN, MD, 20876-7005.

Insiders trading at Senseonics Inc

Over the last 9 years, insiders at Senseonics Inc have traded over $36,720,504 worth of Senseonics Inc stock and bought 30,963,337 units worth $56,759,340 . The most active insiders traders include Peter J Barris, M James Barrett et Douglas A Roeder. On average, Senseonics Inc executives and independent directors trade stock every 45 days with the average trade being worth of $313,683. The most recent stock trade was executed by Sharon Larkin on 7 September 2023, trading 30,889 units of SENS stock currently worth $18,842.

What does Senseonics Inc do?

senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm"​) system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Complete history of Mr. Fiorentino stock trades at Senseonics Inc

Senseonics Inc executives and stock owners

Senseonics Inc executives and other stock owners filed with the SEC include:

• Timothy Goodnow,
  President, Chief Executive Officer, Director
• Francine Kaufman,
  Chief Medical Officer, Director
• Mukul Jain,
  Chief Operating Officer
• Dr. Timothy T. Goodnow,
  Pres, CEO & Director
• Dr. Francine Ratner Kaufman M.D.,
  Chief Medical Officer & Director
• Dr. Mukul Jain,
  Chief Operating Officer
• Mirasol Panlilio,
  Vice President and General Manager - Global Commercial Operations
• Stephen DeFalco,
  Independent Chairman of the Board
• Douglas Prince,
  Independent Director
• Douglas Roeder,
  Independent Director
• Peter Klein,
  Independent Director
• Edward Fiorentino,
  Independent Director
• Steven Edelman,
  Independent Director
• Robert Schumm,
  Director
• Anthony Raab,
  Director
• Nick Tressler,
  Chief Financial Officer, Treasurer, Secretary
• Kenneth L. Horton,
  Gen. Counsel & Corp. Devel. Advisor
• Nick B. Tressler M.B.A.,
  CFO, Sec. & Treasurer
• Sharon Larkin,
  
• Jon D Isaacson,
  Chief Financial Officer
• Michael J. Gill,
  Vice President of U.S. Sales
• M James Barrett,
  Director
• Lynne E Kelley,
  Chief Medical Officer
• Peter J Barris,
  10% owner
• R Don Elsey,
  CFO, Secretary and Treasurer
• Enterprise Associates 9 L P...,
  
• Enterprise Associates 10 L ...,
  
• Management Partners Viii, L...,
  
• Holdings Corp Phc,
  
• John Marotta,
  Director
• Kenneth L Horton,
  GC & Corp. Development Advisor
• Frederick T. Sullivan,
  Chief Financial Officer